Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

OBJECTIVES: The aim of this study was to develop a discrete-time simulation model for people with type 1 diabetes mellitus, to estimate and compare mean life expectancy and quality-adjusted life-years (QALYs) over a lifetime between intensive and conventional blood glucose treatment groups. METHODS:...

Detaylı Bibliyografya
Asıl Yazarlar:	Lung, T, Clarke, P, Hayes, A, Stevens, R, Farmer, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2013

Benzer Materyaller

COST-EFFECTIVENESS OF RENAL SCREENING STRATEGIES AND TREATMENT OPTIONS FOR PATIENTS WITH TYPE 1 DIABETES IN THE UNITED KINGDOM
Yazar:: Lung, T, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
Yazar:: Clarke, P, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
Yazar:: Hayes, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82
Yazar:: Hayes, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Preventing Cardiovascular Complications in Type 1 Diabetes: The Need for a Lifetime Approach
Yazar:: Scott T. Chiesa, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Monitoring Diabetes Mellitus Across the Lifetime of Illness
Yazar:: Farmer, A
Baskı/Yayın Bilgisi: (2008)

Monitoring young people with type 1 diabetes for diabetic nephropathy: potential errors of annual ACR testing.
Yazar:: Oke, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Monitoring young people with type 1 diabetes for diabetic nephropathy: Potential errors of annual ACR testing
Yazar:: Oke, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

An improved model to estimate lifetime health outcomes of patients with type 2 diabetes using 30-year follow-up data from the United Kingdom prospective diabetes study
Yazar:: Hayes, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia.
Yazar:: Hayes, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes
Yazar:: Yuanjie Mao, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Timings for HbA1c testing in people with diabetes are associated with incentive payments: an analysis of UK primary care data
Yazar:: Hirst, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Improving management practices and clinical outcomes in type 2 diabetes study: Prevalence of complications in people with type 2 diabetes in India
Yazar:: Ashok Kumar Das, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes.
Yazar:: Hayes, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database.
Yazar:: Taylor, K, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Macronutrient intake and association with the risk factors of diabetic complications among people with type 2 diabetes
Yazar:: Meena Iqbal Farooqi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications
Yazar:: Tripolino C, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01)

Fish oil in people with type 2 diabetes mellitus.
Yazar:: Farmer, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

How consistent is the relationship between improved glucose control and modelled health outcomes for people with type 2 diabetes mellitus? A systematic Review
Yazar:: Hua, X, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Disparities in the monitoring and complication screening of people with Type 2 diabetes
Yazar:: Hinton, W, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis
Yazar:: Hirst, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Health literacy and cardiovascular complications in people with type 2 Diabetes
Yazar:: Maria Vieira, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes.
Yazar:: Farmer, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Atrophy of the optic chiasm is associated with microvascular diabetic complications in type 1 diabetes
Yazar:: Aleksi Tarkkonen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial
Yazar:: Becker, F, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996–2016
Yazar:: Bendix Carstensen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Educational Needs Associated with the Level of Complication and Comparative Risk Perceptions in People with Type 2 Diabetes
Yazar:: Youngji Hwang, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.
Yazar:: Jianchao Quan, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy
Yazar:: Taylor, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.
Yazar:: Hirst, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Late onset type 1 diabetes.
Yazar:: Lasserson, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Late onset type 1 diabetes
Yazar:: Lasserson, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Late onset type 1 diabetes.
Yazar:: Lasserson, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes.
Yazar:: Barbara H Braffett, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands
Yazar:: Moes RGJ, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Factors associated with diabetes complications among people with type 2 diabetes in Sabah, Malaysia: A cross-sectional study
Yazar:: Alif Ramli, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Association of cardiovascular health with diabetic complications, all-cause mortality, and life expectancy among people with type 2 diabetes
Yazar:: Yuan Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Type 2 diabetes remission trajectories and variation in risk of diabetes complications: a population-based cohort study
Yazar:: Dampha-Miller, H, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

P5.18 CENTRAL HEMODYNAMIC’ S ARE ASSOCIATED WITH DIABETIC COMPLICATIONS IN TYPE 1 DIABETES
Yazar:: S. Theilade, ve diğerleri
Baskı/Yayın Bilgisi: (2013-11-01)

The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications.
Yazar:: Anna Rydén, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)